Dexamethasone treatment for COVID-19 is related to increased mortality in hematologic malignancy patients: results from the EPICOVIDEHA registry - Aiello, Tommaso Francesco; Salmanton-Garcia, Jon; Marchesi, Francesco; Weinbergerova, Barbora; Glenthoj, Andreas; Van Praet, Jens; Farina, Francesca; Davila-Valls, Julio; Martin-Perez, Sonia; El-Ashwah, Shaimaa; Schonlein, Martin; Falces-Romero, Iker; et al. (Haematologica, 2024)
Keywords: Registries; dexamethason; Humans; Hematologic Neoplasms; lidé středního věku; registrace; Female; Aged; dospělí; senioři; lidé; hematologické nádory; Adult; COVID-19; ženské pohlaví; Male; Middle Aged; Dexamethasone; Aged, 80 and over; farmakoterapie COVID-19; senioři nad 80 let; mužské pohlaví; SARS-CoV-2; COVID-19 Drug Treatment